Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Equine protozoal myeloencephalitis.

R J MacKay1, D E Granstrom, W J Saville

  • 1Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.

The Veterinary Clinics of North America. Equine Practice
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Region- and season-specific exposure to lead in a common North American songbird.

Ecotoxicology (London, England)·2026
Same author

Breeding at higher latitude is associated with higher photoperiodic threshold and delayed reproductive development in a songbird.

Hormones and behavior·2020
Same author

Interobserver Variation in the Diagnosis of Neurologic Abnormalities in the Horse.

Journal of veterinary internal medicine·2017
Same author

Effects of clarithromycin, azithromycin and rifampicin on terbutaline-induced sweating in foals.

Equine veterinary journal·2017
Same author

Transcutaneous direct current cardioversion in a foal with lone atrial fibrillation.

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2016
Same author

Spinal Cord Hamartomatous Myelodysplasia in 2 Horses With Clinical Neurologic Deficits.

Veterinary pathology·2016
Same journal

Pharmaceutical and Nutraceutical Therapies for Liver Disease.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Clinical Signs of Liver Disease in Horses.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Syndrome of High Gamma-Glutamyl Transferase in Racehorses.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Equine Hepatology in Practice: Insights, Challenges, and Progress.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Pathophysiology and Treatment of Hepatic Encephalopathy.

The Veterinary clinics of North America. Equine practice·2026
Same journal

Viral Hepatitis.

The Veterinary clinics of North America. Equine practice·2026
See all related articles

Equine protozoal myeloencephalitis (EPM) risk factors include age, season, stress, opossums, and water systems. Treatment significantly improves horse survival and recovery rates.

Area of Science:

  • Veterinary Neurology
  • Parasitology
  • Equine Medicine

Background:

  • Equine protozoal myeloencephalitis (EPM) is a significant neurological disease in horses.
  • Understanding EPM's epidemiology and risk factors is crucial for prevention and management.

Purpose of the Study:

  • To review recent advances in EPM understanding, including life cycle, epidemiology, diagnosis, treatment, and prevention.
  • To identify risk factors associated with EPM development.

Main Methods:

  • Analysis of data from NAHMS Equine '98 study and a retrospective study.
  • Review of recent experimental infection studies and diagnostic test evaluations.

Main Results:

  • Identified risk factors: age (1-5, >13 years), season, stress, opossums, water systems, and wildlife access to feed.

Related Experiment Videos

  • Treatment improved outcomes: 10x more likely to improve, 50x more likely to survive if improved.
  • CSF immunoblot test shows 89% sensitivity and 89% specificity for EPM diagnosis.

    • Conclusions:

    • EPM risk is influenced by various environmental and host factors.
    • Early diagnosis and treatment are critical for improving prognosis in EPM cases.
    • New therapeutic agents show promise for EPM treatment.